Update on Smoking Product Registration and Renewal: What Companies Need to Know
Understand how the update of ANVISA’s guidelines affects the registration and renewal of smoking products and how QR Group can help in the process. ANVISA recently updated its guidelines on the registration and renewal of smoking products derived from tobacco. This change is included in the Collegiate Board Resolution (RDC) 896/2024, which reformulates the requirements […]
ANVISA’s Participation in WHO: Impacts on the Regulation of Medical Products
Understand the Importance of ANVISA’s Role in the Global Product Regulation ANVISA is participating in the 13th plenary meeting of the Member States Mechanism on Substandard and Falsified Medical Products (MSMSF) of the World Health Organization (WHO), reinforcing its essential role in product regulation at the international level. The event will take place between November […]
QR Group Reports: Anvisa Extends Participation Deadline in Pilot Project for Innovative Medical Devices
Understand how the extension of the deadline for the pilot project for regulatory evaluation of innovative medical devices impacts the healthcare sector and how QR Group can help. Anvisa has extended the deadline for submitting Innovative Medical Devices projects in the pilot project for regulatory evaluation, now with a deadline until January 19, 2024. This […]
